Anti-Hemophilic Factor VIII Concentrate from Mexico
A plasma-derived or recombinant Factor VIII concentrate for preventing bleeding in hemophilia A patients. It is a blood fraction and immunological product under HTS 3002.90.52.50, prepared for therapeutic prophylactic use. Essential for clotting factor replacement therapy.
Duty Rate — Mexico → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Provide coagulation activity units per vial and viral safety dossiers
• Ensure lyophilized form with reconstitution instructions for stability
• Avoid bulk plasma classification by specifying patient-ready dosing